Vaxart, Inc. Files 8-K Report
Ticker: VXRT · Form: 8-K · Filed: May 15, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
Related Tickers: VXRT
TL;DR
Vaxart filed an 8-K on 5/15/25, likely with operational or financial updates.
AI Summary
On May 15, 2025, Vaxart, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. No specific new material events or financial figures were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that Vaxart, Inc. is providing updated information to the SEC, which could include material business developments or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate disclosure of significant negative events, suggesting a routine update.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-35285 (identifier) — Commission File Number
- 59-1212264 (identifier) — IRS Employer Identification No.
- 170 Harbor Way, Suite 300, South San Francisco, California 94080 (address) — Principal executive offices
FAQ
What specific "Other Events" are being reported by Vaxart, Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.
What is the significance of Vaxart, Inc. filing under "Financial Statements and Exhibits"?
This indicates that the company is providing updated financial information or exhibits to the SEC, which could include financial statements or related documents.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 15, 2025.
What is Vaxart, Inc.'s state of incorporation and principal executive office location?
Vaxart, Inc. is incorporated in Delaware and its principal executive offices are located at 170 Harbor Way, Suite 300, South San Francisco, California 94080.
Does this 8-K filing provide any new financial figures or material updates?
The provided excerpt of the 8-K filing does not contain specific new financial figures or details of material updates; it only indicates the categories of information being filed.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Vaxart, Inc. (VXRT).